Brief: Expres2ion and NextGen enter a joint venture

Nextgen

21/06/2017 14:59

June 21 (Reuters) - EXPRES2ION BIOTECH HOLDING AB 
 EXPRS2.ST  
    * EXPRES2ION AND NEXTGEN ENTER A JOINT VENTURE FOR 
ACCELERATED DEVELOPMENT OF NEW, IMPROVED VACCINES AND IMMUNE 
THERAPY 
    * FULLY OWNED SUBSIDIARY EXPRES2ION BIOTECHNOLOGIES APS 
("EXPRES2ION") HAS ESTABLISHED A JOINT VENTURE NAMED ADAPTVAC 
APS WITH NEXTGEN VACCINES APS ("NEXTGEN") 
 
Source text for Eikon:  ID:nWkr4XTDvP  
Further company coverage:  EXPRS2.ST  
 
 (Gdynia Newsroom) 
 ((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))